Product Images Bosentan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Bosentan NDC 68180-340 by Lupin Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
bosentan-carton - bosentan 32mg 4x14 unit dose
This text is a detailed description of a medication labeled as "L ETRET" for Oral Suspension tablets. It includes information about phenylketonurics, proper storage conditions, recommended dosage, and instructions for dispensing to patients. The medication guide must be given to each patient along with the prescription. The tablets contain Phenylalanine at 1.85 mg per tablet. It is recommended to disperse the tablets in water before administration and store them at a specific temperature range. Additionally, it mentions the manufacturer and distributor information related to the medication.*
chemical-structure - chemical structure
figure 1 - figure 1
This text provides a list of interacting drugs and recommendations related to their use. It includes names such as Cyclosporin A, Glibenclamide, Simvastatin, Hydroxy acid simvastatin, Norethindrone, and others. The recommendations advise caution in medication usage, monitoring cholesterol levels, and the use of additional contraception.*
figure 2 - figure 2
This is a list of interacting drugs and their effects on other medications. It includes information on Gycosporin A, Lopinavirirtonavic, Rifampin, and their impacts on Ctrough, Gmax, Auc, Cmax, and Foid-2. Recommendations such as contraindication, dose reduction, and frequency of monitoring (e.g., AST/ALT weekly) are provided.*
figure-3 - figure 3
This text contains information regarding drug interactions and the induction of specific enzymes such as CYP3A. It also mentions the interaction with different medications and the recommendations for monitoring and adjustment of dosages to avoid adverse effects. Overall, it provides guidance on potential drug interactions and necessary precautions to be taken while using these medications.*
figure-4 - figure 4
This text provides information on drug interactions involving medications like Cyclosporin A, Lopinavir/ritonavir, Rifampin, Ketoconazole, Losartan, and others. It includes details on enzyme inhibition and induction, substrates, and recommendations such as contraindication, dose reduction, and monitoring. The text also mentions specific enzymes like CYP3A and provides pharmacokinetic parameters like Cmax, AUC, and trough levels.*
figure-5 - figure 5
figure-6 - figure 6
This is a data table showing results over time for a study involving Bosentan and Placebo. The table includes percentages and time in weeks. The specific data points are not clearly listed.*
figure-1 - split tablet images
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
